News

Ask the publishers to restore access to 500,000+ books. An icon used to represent a menu that can be toggled by interacting with this icon. A line drawing of the Internet Archive headquarters building ...
The company said the submission for the vaccine, branded as Spikevax, is based on guidance from the FDA, which advised that the shots should be updated to target strains that are a part of JN.
SPIKEVAX (COVID-19 Vaccine, mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV ...
for review of its Spikevax 2025-2026 formula, targeting the SARS-CoV-2 variant LP.8.1. The submission is based on guidance from the U.S. FDA, which advised that COVID-19 vaccines should be updated ...
The company said the submission for the vaccine, branded as Spikevax, is based on guidance from the FDA, which advised that the shots should be updated to target strains that are a part of JN.1 ...
These vaccines are approved for use in individuals 6 months and older whereas the FDA has approved and authorized updated mRNA COVID-19 vaccines, including Comirnaty and Spikevax, for individuals ...
1 infection ranges from 19% to 49%, based on US research. Several XBB.1.5 monovalent COVID-19 vaccines are available globally, including Pfizer-BioNTech’s Comirnaty and Moderna’s Spikevax (both ...